Europe Companion Animal Diagnostics Market worth $0.70 Billion by 2031
The report "Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031", is projected to reach USD 0.70 Billion by 2031 from USD 0.46 Billion in 2026 at a CAGR of 8.6% during the forecast period.
Browse 250 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-companion-animal-diagnostics-market-57127784.html
Recent advancements in diagnostic tools have significantly enhanced veterinary medicine. The proliferation of rapid point-of-care testing devices and kits has streamlined the diagnostic process, allowing for swift results in both routine examinations and urgent interventions. This capability is particularly beneficial in remote or resource-limited settings, enabling prompt diagnosis of conditions ranging from infections to metabolic disorders. Emerging technologies such as molecular diagnostics and biosensors are at the forefront of modern diagnostics, offering superior sensitivity and specificity. Molecular diagnostics, utilizing techniques such as polymerase chain reaction (PCR), facilitates the detection of viral and bacterial pathogens as well as genetic disorders with high precision. Meanwhile, biosensors are increasingly being employed to monitor chronic conditions, such as diabetes mellitus, in companion animals, providing real-time data that inform treatment decisions. Additionally, advanced imaging technologies, including digital radiography and ultrasonography, significantly improve diagnostic accuracy, particularly for complex cases. These innovations are fundamentally reshaping veterinary healthcare, equipping practitioners with advanced tools that enable timely and effective therapeutic interventions.
This report categorizes the European companion animal diagnostics market based on type, technology, usability, application, end user, and country.
“The consumables segment accounts for the leading share of the Europe companion animal diagnostics market by product.”
With the increase in willingness to spend on findings and the health of pets, there has been a surging demand for high-grade consumables in veterinary test applications. Pet owners consider their furry friends very much part of the family, so they expect the same quality of life for them and therefore demand timely and accurate diagnoses for illnesses and ailments. Increased interest in health and pet wellbeing has led to rapid adoption of advanced tools and consumables such as test kits, reagents, and imaging supplies required by them. Pet owners are fully embracing health maintenance and sometimes diagnostic testing, including regularly planned screens and disease-specific tests. Safe, high-quality diagnostic products ensure the accuracy of test results and the management of diseases that are required by all to keep their pets healthy. An increasing need for superior diagnostic consumables continues to derive from the growing expenditure on pet health, thereby driving the market for companion animal diagnostics.
“By animal type, the dogs segment holds the largest share of the Europe companion animal diagnostics market.”
Dogs are susceptible to various diseases, including cancer, diabetes, and infectious diseases, each necessitating ongoing diagnostic assessments for effective management. The emphasis on continuous monitoring and early detection is driving significant growth of this segment within the European companion animal diagnostics market.
“The UK is expected to exhibit the highest growth rate during the forecast period.”
The UK is the fastest-growing companion animal diagnostics market in Europe. The veterinary diagnostic industry in the country, primarily the companion animal segment, has been growing steadily due to the rising ownership levels of companion animals, the uptake of preventive healthcare practices, and pet insurance coverage, allowing for comprehensive diagnostic procedures to be conducted by veterinary practices.
Key Market Players:
Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include IDEXX (US), Zoetis Services LLC (US), Mars, Incorporated (US), FUJIFILM Corporation (Japan), bioMérieux (France), Thermo Fisher Scientific (US), Virbac (France), Neogen Corporation (US), INDICAL BIOSCIENCE GmbH (Germany), IDvet (France), Randox Laboratories Ltd. (UK), Shenzhen Mindray Animal Medical Technology Co., LTD. (China), Bionote USA Inc. (US), Boule (Sweden), EUROIMMUN Medizinische Labordiagnostika AG (Germany), Biopanda Reagents Ltd (UK), Nova Biomedical (US), Megacor Veterinary Diagnostics (Austria), Eurolyser Diagnostica GmbH (Austria), URIT MEDICAL ELECTRONIC CO., LTD. (China), Fassisi GmbH (Germany), Swissavans AG (Switzerland), Skyla Corporation (Taiwan), Ring Biotechnology Co Ltd (China), and Alvedia (France).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Companion Animal Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
